APA (7th ed.) Citation

MG, B., MS, A., SM, A. F., LD, L., RA, T., AN, C., . . . EA, B. (2025). Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial. Circulation, 152(25), 1742. https://doi.org/10.1161/CIRCULATIONAHA.125.073322

Chicago Style (17th ed.) Citation

MG, Bonatto, et al. "Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial." Circulation 152, no. 25 (2025): 1742. https://doi.org/10.1161/CIRCULATIONAHA.125.073322.

MLA (9th ed.) Citation

MG, Bonatto, et al. "Sacubitril-Valsartan for the Prevention of Anthracycline Cardiotoxicity in Patients With Elevated Cardiac Troponin I Concentration During Chemotherapy: A Double-Blind Randomized Placebo-Controlled Clinical Trial: The SARAH Trial." Circulation, vol. 152, no. 25, 2025, p. 1742, https://doi.org/10.1161/CIRCULATIONAHA.125.073322.